Johns Hopkins University Archives
Jul. 28, 2022—A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.
Nov. 1, 2018—Stephen Baylin, MD, a trailblazer in the study of the epigenetics of cancer, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 8. His lecture, sponsored by the Vanderbilt-Ingram Cancer Center, will begin at 4 p.m. in room 208 Light Hall.
Mar. 28, 2018—Deerfield Management and Vanderbilt University announced March 28 the launch of Ancora Innovation, LLC (“Ancora”), a Deerfield company that will support Vanderbilt’s innovative life science research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.